Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck KgaA Unsolicited Bid For Schering AG Would Create $13.4 Bil. Firm

This article was originally published in The Pink Sheet Daily

Executive Summary

Schering responds that Merck’s €77 per share takeover offer “undervalues” the firm and its future prospects.

You may also be interested in...



Bayer Continues Schering Takeover Bid After Rival Merck Bolsters Holdings

Merck KgaA increased its stake in Schering AG to 10.1% ahead of a June 14 deadline for shareholders to accept Bayer’s takeover offer.

Bayer Continues Schering Takeover Bid After Rival Merck Bolsters Holdings

Merck KgaA increased its stake in Schering AG to 10.1% ahead of a June 14 deadline for shareholders to accept Bayer’s takeover offer.

Bayer Purchase Of Schering AG Would Give Firm Focus On Specialty Pharma

$19. 5 bil. offer by Bayer will likely thwart hostile takeover of Schering by Merck KgaA.

Topics

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel